Human Tra2 proteins jointly control a CHEK1 splicing switch among alternative and constitutive target exons

Nature Communications

Volumn 5, Issue , 2014, Pages

  Best, Andrew ^a   James, Katherine ^b   Dalgliesh, Caroline ^a   Hong, Elaine ^b   Kheirolahi Kouhestani, Mahsa ^a   Curk, Tomaz ^c   Xu, Yaobo ^a   Danilenko, Marina ^a   Hussain, Rafiq ^a   Keavney, Bernard ^a,d   Wipat, Anil ^b   Klinck, Roscoe ^e   Cowell, Ian G ^a   Cheong Lee, Ka ^a   Austin, Caroline A ^a   Venables, Julian P ^a   Chabot, Benoit ^e   Santibanez Koref, Mauro ^a   Tyson Capper, Alison ^b   Elliott, David J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 1; HISTONE H2AX; PROTEIN; RNA BINDING PROTEIN; TRA2 ALPHA PROTEIN; TRA2 BETA PROTEIN; TRA2 PROTEIN; UNCLASSIFIED DRUG; MESSENGER RNA; NERVE PROTEIN; PROTEIN KINASE; TRA2B PROTEIN, HUMAN; TRANSFORMER2 ALPHA PROTEIN, HUMAN;

CHROMOSOME; GENE EXPRESSION; PROTEIN; RNA; VIABILITY;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL VIABILITY; DNA DAMAGE; EXON; GEL MOBILITY SHIFT ASSAY; HEK293 CELL LINE; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MOUSE; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SPLICING DEFECT; WESTERN BLOTTING; GENETICS; METABOLISM; TUMOR CELL LINE;

ALTERNATIVE SPLICING; CELL LINE, TUMOR; EXONS; HUMANS; MCF-7 CELLS; NERVE TISSUE PROTEINS; PROTEIN KINASES; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84923365697     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5760     Document Type: Article

References (74)

1. Fox-Walsh, K. L. & Hertel, K. J. Splice-site pairing is an intrinsically high fidelity process. Proc. Natl Acad. Sci. USA 106, 1766-1771 (2009).
2. Kelemen, O. et al. Function of alternative splicing. Gene 514, 1-30 (2013).
3. Djebali, S. et al. Landscape of transcription in human cells. Nature 489, 101-108 (2012).
4. Ehrmann, I. et al. The tissue-specific RNA binding protein T-STAR controls regional splicing patterns of neurexin pre-mRNAs in the brain. PLoS Genet 9, e1003474 (2013).
5. Venables, J. P. et al. RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues. Mol. Cell Biol. 33, 396-405 (2013).
6. Ule, J. et al. Nova regulates brain-specific splicing to shape the synapse. Nat. Genet. 37, 844-852 (2005).
7. Zhang, C. et al. Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. Genes Dev. 22, 2550-2563 (2008).
8. Llorian, M. et al. Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nat. Struct. Mol. Biol. 17, 1114-1123 (2010).
9. Tsuda, K. et al. Structural basis for the dual RNA-recognition modes of human Tra2-beta RRM. Nucleic Acids Res. 39, 1538-1553 (2011).
10. Elliott, D.J., Best, A., Dalgliesh, C., Ehrmann, I. & Grellscheid, S. How does Tra2beta protein regulate tissue-specific RNA splicing? Biochem Soc Trans 40, 784-8 (2012).
11. Baker, B. S. Sex in flies: the splice of life. Nature 340, 521-524 (1989).
12. Forch, P. & Valcarcel, J. Splicing regulation in Drosophila sex determination. Prog. Mol. Subcell. Biol. 31, 127-151 (2003).
13. Dauwalder, B., Amaya-Manzanares, F. & Mattox, W. A human homologue of the Drosophila sex determination factor transformer-2 has conserved splicing regulatory functions. Proc. Natl Acad. Sci. USA 93, 9004-9009 (1996).
14. Beil, B., Screaton, G. & Stamm, S. Molecular cloning of htra2-beta-1 and htra2-beta-2, two human homologs of tra-2 generated by alternative splicing. DNA Cell Biol. 16, 679-690 (1997).
15. Mende, Y. et al. Deficiency of the splicing factor Sfrs10 results in early embryonic lethality in mice and has no impact on full-length SMN/Smn splicing. Hum. Mol. Genet. 19, 2154-2167 (2010).
16. Roberts, J. M. et al. Splicing factor TRA2B is required for neural progenitor survival. J. Comp. Neurol. 522, 372-392 (2014).
17. Storbeck, M. et al. Neuronal-specific deficiency of the splicing factor tra2b causes apoptosis in neurogenic areas of the developing mouse brain. PLoS ONE 9, e89020 (2014).
18. Grellscheid, S. et al. Identification of evolutionarily conserved exons as regulated targets for the splicing activator tra2beta in development. PLoS Genet. 7, e1002390 (2011).
19. Best, A. et al. Expression of Tra2 beta in cancer cells as a potential contributory factor to neoplasia and metastasis. Int. J. Cell Biol. 2013, 843781 (2013).
20. Hofmann, Y., Lorson, C. L., Stamm, S., Androphy, E. J. & Wirth, B. Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc. Natl Acad. Sci. USA 97, 9618-9623 (2000).
21. Glatz, D. C. et al. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease. J. Neurochem. 96, 635-644 (2006).
22. Long, J. C. & Caceres, J. F. The SR protein family of splicing factors: master regulators of gene expression. Biochem J 417, 15-27 (2009).
23. Zhou, Z. & Fu, X. D. Regulation of splicing by SR proteins and SR protein-specific kinases. Chromosoma 122, 191-207 (2013).
24. Venables, J. P. et al. Up-regulation of the ubiquitous alternative splicing factor Tra2beta causes inclusion of a germ cell-specific exon. Hum. Mol. Genet. 14, 2289-2303 (2005).
25. Busch, A. & Hertel, K. J. Evolution of SR protein and hnRNP splicing regulatory factors. Wiley Interdiscip. Rev. RNA 3, 1-12 (2012).
26. Tacke, R., Tohyama, M., Ogawa, S. & Manley, J. L. Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. Cell 93, 139-148 (1998).
27. Clery, A. et al. Molecular basis of purine-rich RNA recognition by the human SR-like protein Tra2-beta1. Nat. Struct. Mol. Biol. 18, 443-450 (2011).
28. Uren, P. J. et al. Site identification in high-throughput RNA-protein interaction data. Bioinformatics 28, 3013-3020 (2012).
29. Anderson, E. S. et al. The cardiotonic steroid digitoxin regulates alternative splicing through depletion of the splicing factors SRSF3 and TRA2B. RNA 18, 1041-1049 (2012).
30. Lareau, L. F., Inada, M., Green, R. E., Wengrod, J. C. & Brenner, S. E. Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature 446, 926-929 (2007).
31. Stoilov, P., Daoud, R., Nayler, O. & Stamm, S. Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA. Hum. Mol. Genet. 13, 509-524 (2004).
32. Saltzman, A.L., Pan, Q. & Blencowe, B. J. Regulation of alternative splicing by the core spliceosomal machinery. Genes Dev 25, 373-84 (2011).
33. Konig, J. et al. iCLIP-transcriptome-wide mapping of protein-RNA interactions with individual nucleotide resolution. J. Vis. Exp. 50: pii 2638 (2011).
34. Dreszer, T. R. et al. The UCSC Genome Browser database: extensions and updates 2011. Nucleic Acids Res. 40, D918-D923 (2012).
35. Meyer, L. R. et al. The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res. 41, D64-D69 (2013).
36. Stark, C. et al. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 34, D535-D539 (2006).
37. Pabla, N., Bhatt, K. & Dong, Z. Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints. Proc. Natl Acad. Sci. USA 109, 197-202 (2012).
38. Gagou, M. E., Zuazua-Villar, P. & Meuth, M. Enhanced H2AX phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1. Mol. Biol. Cell 21, 739-752 (2010).
39. Syljuasen, R. G. et al. Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. Mol. Cell Biol. 25, 3553-3562 (2005).
40. Melamud, E. & Moult, J. Stochastic noise in splicing machinery. Nucleic Acids Res. 37, 4873-4886 (2009).
41. Chandler, D. S., Qi, J. L. & Mattox, W. Direct repression of splicing by transformer-2. Mol. Cell Biol. 23, 5174-5185 (2003).
42. Skunca, N., Altenhoff, A. & Dessimoz, C. Quality of computationally inferred gene ontology annotations. PLoS Comput. Biol. 8, e1002533 (2012).
43. Smith, E.R. et al. A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16. Mol Cell Biol 25, 9175-88 (2005).
44. Huang, K. et al. Ribosomal RNA gene transcription mediated by the master genome regulator protein CCCTC-binding factor (CTCF) is negatively regulated by the condensin complex. J Biol Chem 288, 26067-77 (2013).
45. Zolk, O. et al. Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem Biophys Res Commun 293, 1377-1382 (2002).
46. Fang, R. et al. LSD2/KDM1B and its cofactor NPAC/GLYR1 endow a structural and molecular model for regulation of H3K4 demethylation. Mol. Cell 49, 558-570 (2013).
47. Schmidt, M. J., West, S. & Norbury, C. J. The human cytoplasmic RNA terminal U-transferase ZCCHC11 targets histone mRNAs for degradation. RNA 17, 39-44 (2011).
48. Fasken, M. B. et al. Air1 zinc knuckles 4 and 5 and a conserved IWRXY motif are critical for the function and integrity of the Trf4/5-Air1/2-Mtr4 polyadenylation (TRAMP) RNA quality control complex. J. Biol. Chem. 286, 37429-37445 (2011).
49. Hagan, J. P., Piskounova, E. & Gregory, R. I. Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 16, 1021-1025 (2009).
50. Westendorf, J.M. et al. M phase phosphoprotein 10 is a human U3 small nucleolar ribonucleoprotein component. Mol Biol Cell 9, 437-49 (1998).
51. Eustermann, S. et al. Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin. Nat. Struct. Mol. Biol. 18, 777-782 (2011).
52. Ule, J. et al. An RNA map predicting Nova-dependent splicing regulation. Nature 444, 580-586 (2006).
53. Spellman, R., Llorian, M. & Smith, C. W. Crossregulation and functional redundancy between the splicing regulator PTB and its paralogs nPTB and ROD1. Mol. Cell 27, 420-434 (2007).
54. Bartek, J., Mistrik, M. & Bartkova, J. Thresholds of replication stress signaling in cancer development and treatment. Nat. Struct. Mol. Biol. 19, 5-7 (2012).
55. Murga, M. et al. Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors. Nat. Struct. Mol. Biol. 18, 1331-1335 (2011).
56. Konig, J. et al. iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat Struct Mol Biol 17, 909-15 (2010).
57. Andrews, S. FastQC A quality control tool for high throughput sequence data. Available at http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.
58. Li, H. seqtk. Available at https://github.com/lh3/seqtk.
59. Krueger, F. Trim Galore! Available at http://www.bioinformatics.babraham. ac.uk/projects/trim-galore/.
60. Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biology 14, R36 (2013).
61. Quinlan, A.R. & Hall, I.M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).
62. Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biology 11, R106 (2010).
63. Anders, S. et al. Detecting differential usage of exons from RNA-seq data. Genome Research 22, 2008-2017 (2012).
64. Bourgeois, C. F., Popielarz, M., Hildwein, G. & Stevenin, J. Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation. Mol. Cell. Biol. 19, 7347-7356 (1999).
65. Grellscheid, S. N. et al. Molecular design of a splicing switch responsive to the RNA binding protein Tra2beta. Nucleic Acids Res. 39, 8092-8104 (2011).
66. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29 (2000).
67. Falcon, S. & Gentleman, R. Using GOstats to test gene lists for GO term association. Bioinformatics 23, 257-258 (2007).
68. Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).
69. Carlson, M. org. Hs.eg.db: Genome wide annotation for Human. R package version 2.8.0. (2012).
70. Rcoreteam. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
71. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504 (2003).
72. Ly, T. et al. A proteomic chronology of gene expression through the cell cycle in human myeloid leukemia cells. Elife 3, e01630 (2014).
73. Liao, H., Winkfein, R. J., Mack, G., Rattner, J. B. & Yen, T. J. CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis. J. Cell Biol. 130, 507-518 (1995).
74. Hendzel, M. J. et al. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106, 348-360 (1997).